@misc{cogprints8871,
          volume = {11},
          number = {1(6)},
           month = {April},
          author = {SC Vella and NB Pai},
          editor = {Dr Srinivas Kakkilaya},
           title = {Prevalence \& Prescription: Prescribing Practices of Clozapine in Australia between 2005 \& 2010},
       publisher = {BS Kakkilaya},
            year = {2012},
         journal = {Online Journal of Health and Allied Sciences},
        keywords = {Clozapine; Treatment-resistant schizophrenia; Prevalence rates; Australia},
             url = {http://cogprints.org/8871/},
        abstract = {Clozapine is an anti-psychotic used to treat refractory schizophrenia. This study reviews the rates of clozapine prescription for refractory schizophrenia in a region of Australia and compares the prescribing patterns to the estimated prevalence rates of refractory schizophrenia in the region. Utilising a pharmacoepidemiological approach; the results indicated that only 8.4\% of the individuals estimated to be suffering from refractory schizophrenia in the region were prescribed clozapine between 2005 and 2010, with only 4.1\% continuing clozapine to the conclusion of the study.  In conclusion it is evident that clozapine is widely under-prescribed in this area of Australia.}
}

<script src='https://archive-bar.soton.ac.uk/archive-bar.js'></script>
<script src='https://archive-bar.soton.ac.uk/google-analytics.js'></script>